Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKinsey
Argus Health
Daiichi Sankyo
Covington
Federal Trade Commission
US Department of Justice
Cipla
McKesson
Merck

Generated: January 21, 2018

DrugPatentWatch Database Preview

Acetohexamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetohexamide and what is the scope of acetohexamide patent protection?

Acetohexamide
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Usl Pharma, Watson Labs Teva, and Lilly, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for acetohexamide.
Medical Subject Heading (MeSH) Categories for acetohexamide

US Patents and Regulatory Information for acetohexamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc ACETOHEXAMIDE acetohexamide TABLET;ORAL 070869-001 Feb 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly DYMELOR acetohexamide TABLET;ORAL 013378-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma ACETOHEXAMIDE acetohexamide TABLET;ORAL 070754-001 Nov 3, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc ACETOHEXAMIDE acetohexamide TABLET;ORAL 070870-001 Feb 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Teva ACETOHEXAMIDE acetohexamide TABLET;ORAL 071894-001 Nov 25, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma ACETOHEXAMIDE acetohexamide TABLET;ORAL 070753-001 Nov 3, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Teva ACETOHEXAMIDE acetohexamide TABLET;ORAL 071893-001 Nov 25, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly DYMELOR acetohexamide TABLET;ORAL 013378-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Cerilliant
Daiichi Sankyo
Accenture
QuintilesIMS
Cipla
Johnson and Johnson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot